386 related articles for article (PubMed ID: 33930530)
1. New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis.
Sun M; Sun Y; Feng Z; Kang X; Yang W; Wang Y; Luo Y
Pharmacol Res; 2021 Jul; 169():105635. PubMed ID: 33930530
[TBL] [Abstract][Full Text] [Related]
2. Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis.
Warren R; Lyu H; Klinkhammer K; De Langhe SP
Elife; 2023 May; 12():. PubMed ID: 37166104
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury.
DiGiovanni GT; Han W; Sherrill TP; Taylor CJ; Nichols DS; Geis NM; Singha UK; Calvi CL; McCall AS; Dixon MM; Liu Y; Jang JH; Gutor SS; Polosukhin VV; Blackwell TS; Kropski JA; Gokey JJ
JCI Insight; 2023 Sep; 8(19):. PubMed ID: 37676731
[TBL] [Abstract][Full Text] [Related]
4. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
[TBL] [Abstract][Full Text] [Related]
5. The Role of Hippo/YAP Signaling in Alveolar Repair and Pulmonary Fibrosis.
Gokey JJ; Patel SD; Kropski JA
Front Med (Lausanne); 2021; 8():752316. PubMed ID: 34671628
[TBL] [Abstract][Full Text] [Related]
6. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
Noguchi S; Saito A; Nagase T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
[TBL] [Abstract][Full Text] [Related]
7. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
8. The Multiple Interactions of RUNX with the Hippo-YAP Pathway.
Chuang LSH; Ito Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831147
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of YAP1-gene Knockdown to Inhibit Alveolar-Epithelial-Cell Senescence and Alleviate Idiopathic Pulmonary Fibrosis (IPF).
Xu W; Song W; Wang YU; Zan Y; Zhang M; Li M; Huang Q; Zhao W; Sun YU; Hoffman RM; Wu J
Cancer Genomics Proteomics; 2021; 18(3 Suppl):451-459. PubMed ID: 33994367
[TBL] [Abstract][Full Text] [Related]
10. Active epithelial Hippo signaling in idiopathic pulmonary fibrosis.
Gokey JJ; Sridharan A; Xu Y; Green J; Carraro G; Stripp BR; Perl AT; Whitsett JA
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563341
[TBL] [Abstract][Full Text] [Related]
11. Hippo signaling pathway and respiratory diseases.
Tang W; Li M; Yangzhong X; Zhang X; Zu A; Hou Y; Li L; Sun S
Cell Death Discov; 2022 Apr; 8(1):213. PubMed ID: 35443749
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts.
Huang LS; Sudhadevi T; Fu P; Punathil-Kannan PK; Ebenezer DL; Ramchandran R; Putherickal V; Cheresh P; Zhou G; Ha AW; Harijith A; Kamp DW; Natarajan V
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192225
[TBL] [Abstract][Full Text] [Related]
13. Hippo signaling pathway in lung development, regeneration, and diseases.
Fu SL; Zhao WY; Zhang WJ; Song H; Ji HB; Tang N
Yi Chuan; 2017 Jul; 39(7):597-606. PubMed ID: 28757474
[TBL] [Abstract][Full Text] [Related]
14. Divergent roles of the Hippo pathway in the pathogenesis of idiopathic pulmonary fibrosis: tissue homeostasis and fibrosis.
Kizawa R; Araya J; Fujita Y
Inflamm Regen; 2023 Sep; 43(1):45. PubMed ID: 37735707
[TBL] [Abstract][Full Text] [Related]
15. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway.
Li C; Zhang R; Zhan Y; Zheng J
Mediators Inflamm; 2021; 2021():3399357. PubMed ID: 34690551
[TBL] [Abstract][Full Text] [Related]
17. A novel role of Hippo-Yap/TAZ signaling pathway in lymphatic vascular development.
Cha B; Moon S; Kim W
BMB Rep; 2021 Jun; 54(6):285-294. PubMed ID: 33691907
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-5 promotes airway smooth muscle cell proliferation and migration via modulating Hippo-YAP/TAZ pathway.
Fu J; Zheng M; Zhang X; Zhang Y; Chen Y; Li H; Wang X; Zhang J
Biochem Biophys Res Commun; 2017 Nov; 493(2):985-991. PubMed ID: 28942149
[TBL] [Abstract][Full Text] [Related]
19. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
Budel SJ; Penning MM; Penning LC
Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
[TBL] [Abstract][Full Text] [Related]
20. Icariin attenuates bleomycin-induced pulmonary fibrosis by targeting Hippo/YAP pathway.
Du W; Tang Z; Yang F; Liu X; Dong J
Biomed Pharmacother; 2021 Nov; 143():112152. PubMed ID: 34536758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
